Personalized polygenic profiling based on the genetic architecture of lipid metabolism in the Russian population - Scorecard - MDSpire

Personalized polygenic profiling based on the genetic architecture of lipid metabolism in the Russian population

  • By

  • Aleksandra Mamchur

  • Maria Bruttan

  • Veronika Daniel

  • Daria Kashtanova

  • Elena Zelenova

  • Irina Dzhumaniiazova

  • Mikhail Ivanov

  • Lorena Matkava

  • Olga Blinova

  • Sergey Mitrofanov

  • Liliya Golubnikova

  • Naiana Kumar

  • Ekaterina Maralova

  • Andrey Shingaliev

  • Marat Ezhov

  • Aleksey Meshkov

  • Uliana Chubykina

  • Olga Pogorelova

  • Mariia Tripoten

  • Tatyana Balahonova

  • Alexandra Viskova

  • Madina Komarova

  • Timur Gurtsiev

  • Natalia Gomyranova

  • Yulia Vorobeva

  • Anastasia Hotuleva

  • Maria Kolyaskina

  • Vladimir Yudin

  • Valentin Makarov

  • Anton Keskinov

  • Lyudmila Kuzmina

  • Sergey Boytsov

  • Sergey Yudin

  • Veronika Skvortsova

  • June 2, 2026

  • 0 min

Share

Clinical Scorecard: Customized Polygenic Analysis of Lipid Metabolism Genetics in the Russian Population

At a Glance

CategoryDetail
ConditionHypercholesterolemia and associated cardiovascular diseases
Key MechanismsGenetic variants affecting lipid metabolism, specifically total cholesterol, LDL-C, and HDL-C levels
Target PopulationRussian population without familial hypercholesterolemia or lipid-regulating agents
Care SettingClinical genetics and cardiovascular risk assessment

Key Highlights

  • Study involved 8,732 participants from the Russian population.
  • Polygenic score models were developed for total cholesterol, LDL-C, and HDL-C.
  • Genetic predictors of lipid levels differed between men and women.
  • Models consider age and BMI for lifelong cardiovascular disease risk assessment.
  • Identified genetic variants linked to lipid levels in specific genes.

Guideline-Based Recommendations

Diagnosis

  • Assess lipid levels and genetic predisposition for hypercholesterolemia.

Management

  • Implement personalized strategies based on polygenic risk scores.

Monitoring & Follow-up

  • Regularly monitor lipid levels and cardiovascular health.

Risks

  • Elevated cholesterol levels increase the risk of atherosclerosis, ischemic heart disease, and myocardial infarction.

Patient & Prescribing Data

Individuals in the Russian population without familial hypercholesterolemia.

Focus on managing modifiable risk factors alongside genetic predisposition.

Clinical Best Practices

  • Utilize whole-genome sequencing for accurate genetic variant identification.
  • Develop ethnicity-specific polygenic risk score models.
  • Incorporate lifestyle factors like BMI in risk assessments.

Related Resources & Content

Original Source(s)

Related Content